Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where ...

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Shares in pharmaceuticals giant Eli Lilly (LLY) were looking perkier today after it ramped up its battle to get a key ...

Historically, the vast majority of pharmaceutical drugs have been meticulously designed down to the atomic level. The ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

Presentations at this year’s American Association for Cancer Research meeting could have a broad impact on the treatment ...